Accenture Ventures has invested in Virtonomy, a provider of data-driven simulations for medical device design.
Virtonomy's cloud-based solution enables digitalizing the design and execution phases of clinical studies for medical devices using digital patient twins.
The technology helps medical device manufacturers build model patient virtual environments for device testing at a reduced cost and with less regulatory complexity.
- Virtonomy's solution uses existing data from clinical trials with children to create virtual environments where medical devices can be easily set up, adjusted, and validated, saving time and still meeting regulatory and ethical demands.
- The investment is part of Accenture Ventures' Project Spotlight, which targets emerging technology software companies.
- Digital twin technology creates a "window of transparency" that frees up more data, according to the Accenture Technology Vision 2023 report.
- Virtonomy plans to use the investment to further extend its capabilities to MedTech companies across the globe and power the future of medical device design.
